Abbott (ABT) sues Teva (TEVA) over its drug for kidney patients, Zemplar
Abbott Labs (NYSE: ABT) sues Teva Pharma (Nasdaq: TEVA) over its drug for kidney patients, Zemplar
Create E-mail AlertRelated Categories
Corporate NewsStocks Mentioned
-0.15Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
